Business
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2025.
About this update from Boston Scientific Corporation
[{"type":"text","content":"ALAMEDA, Calif., Feb. 25, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2025.","length":215,"tagName":"p"},{"type":"image","alt":"Penumbra, Inc. (PRNewsfoto/Penumbra, Inc.)","displaySize":"","headline":null,"caption":"Penumbra, Inc. (PRNewsfoto/Penumbra, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":126,"url":"https://media.zenfs.com/en/prnewswire.com/eb15c61fcc22124ce31d956d65cd4d79"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8EzSY.tjh8uC6JgsDjFj0g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIyMjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/eb15c61fcc22124ce31d956d65cd4d79","width":400,"height":126}},"href":"https://mma.prnewswire.com/media/2652215/Penumbra_Inc_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Financial Highlights:","length":21,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $385.4 million for the fourth quarter of 2025, an increase of 22.1% or 20.9% in constant currency1, compared to the fourth quarter of 2024.","length":150,"tagName":"p"}]},{"val":[{"type":"text","content":"Revenue of $1,403.7 million for the full year 2025, an increase of 17.5% or 16.9% in constant currency1, compared to the full year 2024.","length":136,"tagName":"p"}]},{"val":[{"type":"text","content":"U.S. Thrombectomy revenue of $203.1 million for the fourth quarter of 2025, an increase of 12.4% compared to the fourth quarter of 2024.","length":136,"tagName":"p"}]},{"val":[{"type":"text","content":"U.S. Thrombectomy revenue of $771.5 million for the full year 2025, an increase of 19.3% compared to the full year 2024.","length":120,"tagName":"p"}]},{"val":[{"type":"text","content":"Income from operations of $59.2 million or operating margin of 15.4% for the fourth quarter of 2025. ","length":100,"tagName":"p"}]},{"val":[{"type":"text","content":"Income from operations of $189.2 million or operating margin of 13.5% for the full year 2025.","length":93,"tagName":"p"}]},{"val":[{"type":"text","content":"Net income of $47.3 million and adjusted EBITDA1 of $79.1 million or net income margin of 12.3% and adjusted EBITDA margin1 of 20.5% for the fourth quarter of 2025. ","length":164,"tagName":"p"...